Abstract
The skin and the central and peripheral nervous system both derive from the ectoderm ridge. Therefore, several syndromes characterized by the presence of intellectual disability (ID) can be associated with specific congenital cutaneous manifestations. In this review, we list some of the most frequent diseases characterized by the presence of ID associated with hirsutism, which might be an incentive for the clinicians to pay attention to the ectodermal annexes in patients with ID.
Keywords: intellectual disability, hypertrichosis, hair, hirsutism
Introduction
Embryologically, the skin and the central and peripheral nervous system share a common source, the ectoderm. Therefore, intellectual disability (ID) can be frequently associated with specific congenital cutaneous manifestations, the discovery of which can facilitate the final diagnosis, leading to specific treatment and/or targeted genetic tests. Careful examination of the skin, hair, and nails by the pediatrician or neurologist is consequently of great importance.1
Terminal hypertrichosis is characterized by the excessive growth of terminal hair that may be generally caused by alteration of its growth cycle, conversion of vellus into terminal hair, or increase in the density of hair follicles. Here we present the most frequent inherited syndromes characterized by hypertrichosis associated with ID, to help nondermatologists to unravel and address the correct diagnosis.
Cornelia de Lange Syndrome
Cornelia de Lange syndrome (CdLS; OMIM 122740, 300590, 610759, and 614701), also known as Brachmann-de Lange syndrome, is a rare genetic disease with an overall prevalence for mild and classical CdLS of approximately 1.6–2.2:100,000.2 This clinically hypervariable disease can be characterized by the presence of typical facial dysmorphisms, microcephaly, pre- and postnatal growth impairment, and multisystemic manifestations particularly ID, limb defects, hirsutism, congenital heart malformations, and gastrointestinal diseases.3 The classical CdLS phenotype typically shows distinctive facial features including low anterior hairline, arched eyebrows, synophrys, thick and long eyelashes, depressed nasal bridge, long philtrum, down-turned corners of the lips, and micrognathia.3 Ears may be thick, dysplastic, low-set, and posteriorly rotated, and the ear canal tends to be narrow or stenotic. Hands and feet are small, with malformed hands in nearly 30% of the patients (from oligodactyly to ulnar deficiency to absent forearm, with digits present just distal to the elbow). In addition, there can be a dislocation of the radial head with radioulnar synostosis.3 A generalized hirsutism is common (78% of the patients) and most noticeable on the face, back, and extremities.
Development is typically delayed, with a range from borderline IQ with learning disabilities to profound ID, although individuals with IQ in the normal range have been reported. Speech and language are the most severely affected developmental areas, 44 to 53% of patients being late talkers, 61 to 67% limited talkers, and 33% are nontalkers.4 5 Epilepsy is frequently reported,6 and typical imaging manifestations of CdLS include skull base dysplasia with coronal clival cleft, cerebral and brainstem volume loss, and gyral simplification.7 Common behavioral issues are hyperactivity, attention deficit disorder with or without hyperactivity, aggression, self-injurious behavior, obsessive-compulsive behaviors, and depression.8
Gastroesophageal reflux disease is extremely common (90%), and often requires medical and/or surgical intervention.9 10 An increased risk of volvulus (2–3%) is seen in patients with CdLS.11 Congenital heart malformations, often a ventricular or atrial septal defect, occur in 20% of the patients.12 Up to 60% of the patients have some degree of sensorineural and conductive hearing loss.13 Myopia, ptosis, and blepharitis are common. Renal malformations are reported in about the 40% of cases, with vesicoureteral reflux, pelvic dilatation, or renal dysplasia. Finally, genitalia are dysplastic in up to 60% of affected individuals.3
Mutations in five genes, encoding subunits of the cohesin complex (SMC1A, SMC3, RAD21) and its regulators (NIPBL, HDAC8), account for at least 70% of patients with CdLS or CdLS-like phenotypes. Almost all cases are sporadic and are caused by de novo heterozygous loss-of-function mutations in NIPBL (65%), with mosaic individuals representing a significant proportion (up to 23%),14 while heterozygous mutations in the autosomal genes SMC3 and RAD21 and heterozygous or hemizygous mutations in the X-linked SMC1A and HDAC8 have been reported in approximately 6% of CdLS cases. These cases mostly overlap the classical phenotype caused by mutations in NIPBL, but usually lack limb and internal malformations, and they have less severe growth impairment and the gestalt is milder. In particular, a recent study15 deepened the genotype–phenotype correlation of the patients with missense or in-frame insertions or deletions in SMC3 and found that postnatal microcephaly is present but with a less distinctive craniofacial appearance. In addition, few congenital heart defects, absence of limb deficiencies, and a milder prenatal growth retardation which worsens in childhood can be observed.
Conversely, mutations in HDAC8 seem to be linked to a craniofacial appearance typical of CdLS associated with delayed anterior fontanelle closure, ocular hypertelorism, hooding of the eyelids, a broader nose, and dental anomalies. As complete loss of HDAC8 function appears to be viable in humans, the range of phenotypes varies from more affected males to apparently unaffected carrier females, usually with a heavily skewed X-inactivation.16
All the protein products of the known CdLS genes are part of the cohesin complex, a structure involved in sister chromatid cohesion and in transcriptional regulation in nondividing cells.17 18
Wiedemann-Steiner Syndrome
Wiedemann-Steiner Syndrome (WSS, OMIM#: 605130) is a clinical entity defined by a wide spectrum of associated features accompanied by the hallmark of the disease that should be a localized form of hypertrichosis terminalis of the extensor surfaces of the distal upper arm and proximal forearm, named hypertrichosis cubiti or hairy elbows.19 20 Actually, the recent discovery of the causal gene (KMT2A)21 allowed to expand the phenotype to diffuse hypertrichosis without hairy elbows.22 The additional features that are frequently reported are postnatal growth retardation, ID, mild to moderate developmental delay, and short stature with a slim and muscular build. The facial appearance is typical and characterized by hypertelorism, thick or arched eyebrows, long eyelashes, down slanting and vertically narrow palpebral fissures, broad nasal bridge, and tented upper lip.23 24 25 Other rarer features observed in some WSS patients include high narrow palate, sacral dimple, tapering fingers, fifth finger clinodactyly, hypotonia, advanced bone age,26 and premature eruption of adult teeth.22
As previously mentioned, haploinsufficiency of KMT2A gene, also known as MLL, has been recently reported to underlie the WSS phenotype, but no KMT2A alterations have been observed in several WSS patients, suggesting a possible locus heterogeneity. KMT2A encodes for a histone methyltransferase that promotes the transcription through the catalysis of the methylation on the histone H3K4. It has been demonstrated that KMT2A is ubiquitously expressed, and in mammalian embryos it maintains the expression of Hox genes,27 which are clusters of primary importance for a proper embryo morphogenesis.28
The hypertrichosis, as well as the other features observed in these patients, is probably the result of the disruption of the genomic distribution and timing of histone-methylation events, causing secondary effects on transcription.
Nicolaides–Baraitser and Coffin–Siris Syndromes
Nicolaides–Baraitser syndrome (NBS; OMIM#601358) and Coffin–Siris syndrome (CSS; OMIM#135900) are two rare congenital multiple malformation syndromes with overlapping clinical characteristics as ID with absent or limited speech, coarsening of the facial features with age, and brachydactyly. Additionally, there may be seizures, feeding difficulties, hypotonia, short stature, and microcephaly, while isolated or multiple congenital anomalies, as heart defects and hearing impairment, seem to be rare,29 30 even if a casuistry estimates that the rate of heart malformations may be approximately 30%.31 Regarding the hair, almost all the patients show low anterior hairline with sparse scalp hair with hair shaft abnormalities including trichoschisis and trichorrhexis nodosa-like defects at light microscopy examination.32 On the contrary, hypertrichosis is usually present all over the body. The facies, as mentioned earlier, becomes progressively coarse, especially in CSS, and it is characterized by a triangular shape with low frontal hairline, bushy eyebrows with or without synophrys, long philtrum, and big mouth with thin upper lip and thick and everted lower lip. Classically, the differential diagnosis between the two syndromes was based on the hands and feet aspect, as NBS patients present prominent finger joints and broad distal phalanges, while CSS patients display hypo- or aplasia of the fifth finger nails with or without hypoplasia of the phalanges.32 However, the diagnosis is often difficult because several CSS and NBS patients have little or no fifth digit involvement, and, for example, mutations of genes classically mutated in CSS patients can also lead to NBS phenotypes.33
In 2012, mutations in genes encoding for members of the SWItch/sucrose nonfermentable (SWI/SNF) complex were identified as the cause for CSS34 35 and included the genes ARID1A, ARID1B, SMARCA4, SMARCB1, and SMARCE1. Recently, SOX11, a transcription factor downstream of the PAX6-BAF complex, has been added to the list.35 Interestingly, mutations in SMARCA2, a gene encoding for another subunit of the SWI/SNF complex, have been shown to cause NBS,36 underlining the effective molecular as well as clinical overlap between the two syndromes and justifying the difficulties that the clinicians often have to deal with in the differential diagnosis. All these aspects had led to believe that these syndromes might represent a phenotypic spectrum rather than two distinct disorders.
In the last few years, a better genotype–phenotype correlation of some of the causal genes has emerged.37 38 For example, ARID1B seems to be the major gene involved in CSS and correlates with a milder phenotype.33 39 This gene is probably a component of the neuron-specific chromatin remodeling complex and, besides CSS phenotype, haploinsufficiency of this gene can also lead to nonsyndromic ID40 or ID, autism, and corpus callosum abnormalities.41 Mutations in SMARCE1 and SMARCB1 lead to a more severe CSS, with SMARCE1 causing severe ID, feeding difficulties, seizures, heart defects, and long and slender fingers with hypoplasia of the second and aplasia of the fifth fingernails, while all toenails are often dystrophic. Mutations within exons 8 and 9 of SMARCB1 seem to lead to severe CSS with midface hypoplasia, up slanting palpebral fissures and tongue protrusion, scoliosis, and visual or hearing impairment. Mutations in the SMARCA4 gene37 classically lead to moderate–severe ID, behavioral abnormalities, fingernails hypoplasia, hirsutism, cardiovascular and gastrointestinal complications and hernia, and sometimes visual or hearing impairment, and patients are prone to infections. Patient with ARID1A loss-of-function mutations generally showed a marked hirsutism, hypotonia and structural CNS abnormalities, severe developmental delay/ID, and serous internal complications that could result in early death, whereas milder phenotypes were also reported.37 Finally, de novo loss-of-function mutations in the X chromosomal gene PHF6 in females seem to lead to a complete CSS phenotype,33 although this gene has been previously described as causal gene of Borjeson–Forssman–Lehmann syndrome (MIM 301900).42 The gene product interacts with the nucleosome remodeling and deacetylation complex that has similar functions as the SWI/SNF complex in transcriptional regulation.
Of note, in several CSS and NCS patients, no mutations within the SWI/SNF complex have been identified yet, pointing toward further genetic heterogeneity of the disorders.
Zimmermann–Laband Syndrome
Zimmermann–Laband syndrome (ZLS; OMIM #135500) belongs to a phenotypically heterogeneous group of conditions characterized by ID with skeletal and mucocutaneous findings as Cantù and DOOR syndromes. Literature review showed that the main features of the syndrome are gingival hypertrophy associated with nails or terminal phalanges hypo/aplasia (100% of patients).43 44 45 46 47 48 49 50 In more than 50% of the patients, a typical facial appearance is detectable, characterized by thick ears, large and bulbous nose, and thick lips with or without macrostomia. Common reported clinical features are moreover ID (more than 40%), joints hypermobility (48%), hypertrichosis of the face and/or the body (37%), hepatosplenomegaly (27%), and seizures (13%).50 Clinical variability is wide even in the same family, and, as commonly observed, the seriousness of the somatic involvement often does not correlate with the severity of the ID. Several other rarer signs have been reported, as pigmentation disorders,43 49 supernumerary teeth,45 46 49 ocular anomalies,47 49 and others.44 48 49 This wide spectrum of clinical presentations of ZLS reported in the literature could be partly due to the absence, to date, of any confirmatory diagnostic test aimed at clearly defining the ZLS phenotype as compared with the overlapping conditions (DOOR and Cantù syndromes). However, Kortüm and colleagues51 have just reported that heterozygous missense mutations in KCNH1 leading to gain-of-function effect account for a considerable proportion of ZLS, and that recurrent de novo missense change in ATP6V1B2 could be a second molecular cause of ZLS. This discovery, together with the recent explanation, although partial, of the molecular bases of Cantù and DOOR syndromes,52 53 will permit to better characterize these phenotypes.
X-Linked Intellectual Disability Type Nascimento
X-linked syndromic ID type Nascimento (MRXSN, MIM #300860) was first described as a distinct entity in 2006 by Nascimento and colleagues.54
The syndrome is clinically characterized by a pronounced ID, seizures in some patients, a recognizable face, macrocephaly, skin abnormalities, and urogenital malformations.
The ID is usually severe, with impairment or even absent speech, walking age between 1 and 5 years, or no walking ability, and seizures in about 62% of the patients, while cerebral MRI shows white matter alterations in approximately 50% of cases.55 56 In up to 75% of patients, skin abnormalities are detectable and include generalized hirsutism, dry skin with myxedematous appearance, widely spaced nipples, and onychodystrophy, which usually appear at puberty.56
Urogenital findings comprise especially micropenis and ureteral reflux (65% of the reported patients). Regarding the typical craniofacial dysmorphisms, the patients show macrocephaly, wide face, prominent supraorbital ridges, synophrys or straight and thick eyebrows, hypertelorism, deep-set and almond-shaped eyes, up slanting palpebral fissures, depressed nasal bridge, prominent columella and hypoplastic alae nasi, and macrostomia with downturned corners of the mouth.56 57 Other less frequently associated features are recurrent infections with or without neutropenia, heart defects, hearing loss, various digital anomalies (proximally inserted thumbs and short and slender fingers), congenital cataract, and preauricular pits.54 56
Intragenic mutations of UBE2A 54 56 58 as well as larger deletions encompassing this gene55 56 57 59 have been described as causative of the MRXSN clinical phenotype.54 While all affected males show the typical phenotype, all female carriers are clinically unaffected and showed a completely skewed X-inactivation; nevertheless, subtle facial features might be detected.58
Conclusion
This is a small review of the most frequent diseases characterized by the presence of ID associated with hypertrichosis. Obviously, several contiguous gene syndromes, such as duplication 3q26.1–3q28,60 deletion 8q24,61 and other complex chromosomal imbalance, could cause this association, and this review is not exhaustive of this argument, but it might be an incentive for the clinicians to observe the ectodermal annexes in a patient with ID.
References
- 1.Neau J P, Godeneche G, Mathis S, Guillet G. Neurodermatology. Handb Clin Neurol. 2014;121:1561–1594. doi: 10.1016/B978-0-7020-4088-7.00104-8. [DOI] [PubMed] [Google Scholar]
- 2.Barisic I, Tokic V, Loane M. et al. Descriptive epidemiology of Cornelia de Lange syndrome in Europe. Am J Med Genet A. 2008;146A(1):51–59. doi: 10.1002/ajmg.a.32016. [DOI] [PubMed] [Google Scholar]
- 3.Kline A D, Krantz I D, Sommer A. et al. Cornelia de Lange syndrome: clinical review, diagnostic and scoring systems, and anticipatory guidance. Am J Med Genet A. 2007;143A(12):1287–1296. doi: 10.1002/ajmg.a.31757. [DOI] [PubMed] [Google Scholar]
- 4.Goodban M T. Survey of speech and language skills with prognostic indicators in 116 patients with Cornelia de Lange syndrome. Am J Med Genet. 1993;47(7):1059–1063. doi: 10.1002/ajmg.1320470725. [DOI] [PubMed] [Google Scholar]
- 5.Sarimski K. Analysis of intentional communication in severely handicapped children with Cornelia-de-Lange syndrome. J Commun Disord. 2002;35(6):483–500. doi: 10.1016/s0021-9924(02)00117-x. [DOI] [PubMed] [Google Scholar]
- 6.Pavlidis E, Cantalupo G, Bianchi S, Piccolo B, Pisani F. Epileptic features in Cornelia de Lange syndrome: case report and literature review. Brain Dev. 2014;36(10):837–843. doi: 10.1016/j.braindev.2013.12.008. [DOI] [PubMed] [Google Scholar]
- 7.Whitehead M T, Nagaraj U D, Pearl P L. Neuroimaging features of Cornelia de Lange syndrome. Pediatr Radiol. 2015;45(8):1198–1205. doi: 10.1007/s00247-015-3300-5. [DOI] [PubMed] [Google Scholar]
- 8.Ajmone P F, Rigamonti C, Dall'Ara F. et al. Communication, cognitive development and behavior in children with Cornelia de Lange Syndrome (CdLS): preliminary results. Am J Med Genet B Neuropsychiatr Genet. 2014;165B(3):223–229. doi: 10.1002/ajmg.b.32224. [DOI] [PubMed] [Google Scholar]
- 9.Luzzani S, Macchini F, Valadè A, Milani D, Selicorni A. Gastroesophageal reflux and Cornelia de Lange syndrome: typical and atypical symptoms. Am J Med Genet A. 2003;119A(3):283–287. doi: 10.1002/ajmg.a.20191. [DOI] [PubMed] [Google Scholar]
- 10.Hamilton J, Clement W A, Kubba H. Otolaryngological presentations of Cornelia de Lange syndrome. Int J Pediatr Otorhinolaryngol. 2014;78(9):1548–1550. doi: 10.1016/j.ijporl.2014.05.032. [DOI] [PubMed] [Google Scholar]
- 11.Holthusen J, Røttingen J A. Cecal volvulus as a complication in Cornelia de Lange syndrome. A case report and literature review [in Norwegian] Tidsskr Nor Laegeforen. 1998;118(10):1559–1560. [PubMed] [Google Scholar]
- 12.Selicorni A, Colli A M, Passarini A. et al. Analysis of congenital heart defects in 87 consecutive patients with Brachmann-de Lange syndrome. Am J Med Genet A. 2009;149A(6):1268–1272. doi: 10.1002/ajmg.a.32838. [DOI] [PubMed] [Google Scholar]
- 13.Marchisio P, Selicorni A, Bianchini S. et al. Audiological findings, genotype and clinical severity score in Cornelia de Lange syndrome. Int J Pediatr Otorhinolaryngol. 2014;78(7):1045–1048. doi: 10.1016/j.ijporl.2014.03.038. [DOI] [PubMed] [Google Scholar]
- 14.Ansari M, Poke G, Ferry Q. et al. Genetic heterogeneity in Cornelia de Lange syndrome (CdLS) and CdLS-like phenotypes with observed and predicted levels of mosaicism. J Med Genet. 2014;51(10):659–668. doi: 10.1136/jmedgenet-2014-102573. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Gil-Rodríguez M C, Deardorff M A, Ansari M. et al. De novo heterozygous mutations in SMC3 cause a range of Cornelia de Lange syndrome-overlapping phenotypes. Hum Mutat. 2015;36(4):454–462. doi: 10.1002/humu.22761. [DOI] [PubMed] [Google Scholar]
- 16.Kaiser F J, Ansari M, Braunholz D. et al. Loss-of-function HDAC8 mutations cause a phenotypic spectrum of Cornelia de Lange syndrome-like features, ocular hypertelorism, large fontanelle and X-linked inheritance. Hum Mol Genet. 2014;23(11):2888–2900. doi: 10.1093/hmg/ddu002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Nasmyth K, Haering C H. Cohesin: its roles and mechanisms. Annu Rev Genet. 2009;43:525–558. doi: 10.1146/annurev-genet-102108-134233. [DOI] [PubMed] [Google Scholar]
- 18.Kaur M, DeScipio C, McCallum J. et al. Precocious sister chromatid separation (PSCS) in Cornelia de Lange syndrome. Am J Med Genet A. 2005;138(1):27–31. doi: 10.1002/ajmg.a.30919. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.MacDermot K D, Patton M A, Williams M J, Winter R M. Hypertrichosis cubiti (hairy elbows) and short stature: a recognisable association. J Med Genet. 1989;26(6):382–385. doi: 10.1136/jmg.26.6.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Edwards M J, Crawford A E, Jammu V, Wise G. Hypertrichosis “cubiti” with facial asymmetry. Am J Med Genet. 1994;53(1):56–58. doi: 10.1002/ajmg.1320530112. [DOI] [PubMed] [Google Scholar]
- 21.Jones W D, Dafou D, McEntagart M. et al. De novo mutations in MLL cause Wiedemann-Steiner syndrome. Am J Hum Genet. 2012;91(2):358–364. doi: 10.1016/j.ajhg.2012.06.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Strom S P, Lozano R, Lee H. et al. De Novo variants in the KMT2A (MLL) gene causing atypical Wiedemann-Steiner syndrome in two unrelated individuals identified by clinical exome sequencing. BMC Med Genet. 2014;15:49. doi: 10.1186/1471-2350-15-49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Polizzi A, Pavone P, Ciancio E, La Rosa C, Sorge G, Ruggieri M. Hypertrichosis cubiti (hairy elbow syndrome): a clue to a malformation syndrome. J Pediatr Endocrinol Metab. 2005;18(10):1019–1025. doi: 10.1515/jpem.2005.18.10.1019. [DOI] [PubMed] [Google Scholar]
- 24.Visser R, Beemer F A, Veenhoven R H, De Nef J J. Hypertrichosis cubiti: two new cases and a review of the literature. Genet Couns. 2002;13(4):397–403. [PubMed] [Google Scholar]
- 25.Miyake N, Tsurusaki Y, Koshimizu E. et al. Delineation of clinical features in Wiedemann-Steiner syndrome caused by KMT2A mutations. Clin Genet. 2015 doi: 10.1111/cge.12586. [DOI] [PubMed] [Google Scholar]
- 26.Mendelsohn B A, Pronold M, Long R, Smaoui N, Slavotinek A M. Advanced bone age in a girl with Wiedemann-Steiner syndrome and an exonic deletion in KMT2A (MLL) Am J Med Genet A. 2014;164A(8):2079–2083. doi: 10.1002/ajmg.a.36590. [DOI] [PubMed] [Google Scholar]
- 27.Milne T A, Briggs S D, Brock H W. et al. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell. 2002;10(5):1107–1117. doi: 10.1016/s1097-2765(02)00741-4. [DOI] [PubMed] [Google Scholar]
- 28.Quinonez S C, Innis J W. Human HOX gene disorders. Mol Genet Metab. 2014;111(1):4–15. doi: 10.1016/j.ymgme.2013.10.012. [DOI] [PubMed] [Google Scholar]
- 29.Sousa S B, Abdul-Rahman O A, Bottani A. et al. Nicolaides-Baraitser syndrome: Delineation of the phenotype. Am J Med Genet A. 2009;149A(8):1628–1640. doi: 10.1002/ajmg.a.32956. [DOI] [PubMed] [Google Scholar]
- 30.Schrier S A, Bodurtha J N, Burton B. et al. The Coffin-Siris syndrome: a proposed diagnostic approach and assessment of 15 overlapping cases. Am J Med Genet A. 2012;158A(8):1865–1876. doi: 10.1002/ajmg.a.35415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Nemani L, Barik R, Patnaik A N, Mishra R C, Rao A M, Kapur P. Coffin-Siris syndrome with the rarest constellation of congenital cardiac defects: a case report with review of literature. Ann Pediatr Cardiol. 2014;7(3):221–226. doi: 10.4103/0974-2069.140859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Mari F, Marozza A, Mencarelli M A. et al. Coffin-Siris and Nicolaides-Baraitser syndromes are a common well recognizable cause of intellectual disability. Brain Dev. 2015;37(5):527–536. doi: 10.1016/j.braindev.2014.08.009. [DOI] [PubMed] [Google Scholar]
- 33.Wieczorek D, Bögershausen N, Beleggia F. et al. A comprehensive molecular study on Coffin-Siris and Nicolaides-Baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered chromatin remodeling. Hum Mol Genet. 2013;22(25):5121–5135. doi: 10.1093/hmg/ddt366. [DOI] [PubMed] [Google Scholar]
- 34.Santen G W, Aten E, Sun Y. et al. Mutations in SWI/SNF chromatin remodeling complex gene ARID1B cause Coffin-Siris syndrome. Nat Genet. 2012;44(4):379–380. doi: 10.1038/ng.2217. [DOI] [PubMed] [Google Scholar]
- 35.Tsurusaki Y, Okamoto N, Ohashi H. et al. Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. Nat Genet. 2012;44(4):376–378. doi: 10.1038/ng.2219. [DOI] [PubMed] [Google Scholar]
- 36.Van Houdt J K Nowakowska B A Sousa S B et al. Heterozygous missense mutations in SMARCA2 cause Nicolaides-Baraitser syndrome Nat Genet 2012444445–449., S1 [DOI] [PubMed] [Google Scholar]
- 37.Kosho T Okamoto N; Coffin-Siris Syndrome International Collaborators. Genotype-phenotype correlation of Coffin-Siris syndrome caused by mutations in SMARCB1, SMARCA4, SMARCE1, and ARID1A Am J Med Genet C Semin Med Genet 2014166C3262–275. [DOI] [PubMed] [Google Scholar]
- 38.Santen G W, Aten E, Vulto-van Silfhout A T. et al. Coffin-Siris syndrome and the BAF complex: genotype-phenotype study in 63 patients. Hum Mutat. 2013;34(11):1519–1528. doi: 10.1002/humu.22394. [DOI] [PubMed] [Google Scholar]
- 39.Sim J CH, White S M, Lockhart P J. ARID1B-mediated disorders: mutations and possible mechanisms. Intractable Rare Dis Res. 2015;4(1):17–23. doi: 10.5582/irdr.2014.01021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Hoyer J, Ekici A B, Endele S. et al. Haploinsufficiency of ARID1B, a member of the SWI/SNF-a chromatin-remodeling complex, is a frequent cause of intellectual disability. Am J Hum Genet. 2012;90(3):565–572. doi: 10.1016/j.ajhg.2012.02.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Halgren C, Kjaergaard S, Bak M. et al. Corpus callosum abnormalities, intellectual disability, speech impairment, and autism in patients with haploinsufficiency of ARID1B. Clin Genet. 2012;82(3):248–255. doi: 10.1111/j.1399-0004.2011.01755.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Lower K M, Turner G, Kerr B A. et al. Mutations in PHF6 are associated with Börjeson-Forssman-Lehmann syndrome. Nat Genet. 2002;32(4):661–665. doi: 10.1038/ng1040. [DOI] [PubMed] [Google Scholar]
- 43.Giansanti J S, McKenzie W T, Owens F C. Gingival fibromatosis, hypertelorism, anti-mongoloid obliquity, multiple telangiectases and cafe au lait pigmentation; a unique combination of developmental anomalies. J Periodontol. 1973;44(5):299–302. doi: 10.1902/jop.1973.44.5.299. [DOI] [PubMed] [Google Scholar]
- 44.Anavi Y, Lerman P, Mintz S, Kiviti S. Idiopathic familial gingival fibromatosis associated with mental retardation, epilepsy and hypertrichosis. Dev Med Child Neurol. 1989;31(4):538–542. doi: 10.1111/j.1469-8749.1989.tb04033.x. [DOI] [PubMed] [Google Scholar]
- 45.Chadwick B, Hunter B, Hunter L, Aldred M, Wilkie A. Laband syndrome. Report of two cases, review of the literature, and identification of additional manifestations. Oral Surg Oral Med Oral Pathol. 1994;78(1):57–63. doi: 10.1016/0030-4220(94)90118-x. [DOI] [PubMed] [Google Scholar]
- 46.Holzhausen M, Gonçalves D, Corrêa FdeO, Spolidorio L C, Rodrigues V C, Orrico S R. A case of Zimmermann-Laband syndrome with supernumerary teeth. J Periodontol. 2003;74(8):1225–1230. doi: 10.1902/jop.2003.74.8.1225. [DOI] [PubMed] [Google Scholar]
- 47.Shah N, Gupta Y K, Ghose S. Zimmermann-Laband syndrome with bilateral developmental cataract - a new association? Int J Paediatr Dent. 2004;14(1):78–85. doi: 10.1111/j.1365-263x.2004.00471.x. [DOI] [PubMed] [Google Scholar]
- 48.Balasubramanian M, Parker M J. Zimmermann-Laband syndrome in a child previously described with brachydactyly, extrahepatic biliary atresia, patent ductus arteriosus and seizures. Clin Dysmorphol. 2010;19(1):48–50. doi: 10.1097/MCD.0b013e328333c239. [DOI] [PubMed] [Google Scholar]
- 49.Chacon-Camacho O F, Vázquez J, Zenteno J C. Expanding the phenotype of gingival fibromatosis-mental retardation-hypertrichosis (Zimmermann-Laband) syndrome. Am J Med Genet A. 2011;155A(7):1716–1720. doi: 10.1002/ajmg.a.34030. [DOI] [PubMed] [Google Scholar]
- 50.Castori M, Valiante M, Pascolini G, Leuzzi V, Pizzuti A, Grammatico P. Clinical and genetic study of two patients with Zimmermann-Laband syndrome and literature review. Eur J Med Genet. 2013;56(10):570–576. doi: 10.1016/j.ejmg.2013.08.004. [DOI] [PubMed] [Google Scholar]
- 51.Kortüm F, Caputo V, Bauer C K. et al. Mutations in KCNH1 and ATP6V1B2 cause Zimmermann-Laband syndrome. Nat Genet. 2015;47(6):661–667. doi: 10.1038/ng.3282. [DOI] [PubMed] [Google Scholar]
- 52.Harakalova M, van Harssel J J, Terhal P A. et al. Dominant missense mutations in ABCC9 cause Cantú syndrome. Nat Genet. 2012;44(7):793–796. doi: 10.1038/ng.2324. [DOI] [PubMed] [Google Scholar]
- 53.Campeau P M, Kasperaviciute D, Lu J T. et al. The genetic basis of DOORS syndrome: an exome-sequencing study. Lancet Neurol. 2014;13(1):44–58. doi: 10.1016/S1474-4422(13)70265-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Nascimento R MP, Otto P A, de Brouwer A PM, Vianna-Morgante A M. UBE2A, which encodes a ubiquitin-conjugating enzyme, is mutated in a novel X-linked mental retardation syndrome. Am J Hum Genet. 2006;79(3):549–555. doi: 10.1086/507047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.de Leeuw N, Bulk S, Green A. et al. UBE2A deficiency syndrome: Mild to severe intellectual disability accompanied by seizures, absent speech, urogenital, and skin anomalies in male patients. Am J Med Genet A. 2010;152A(12):3084–3090. doi: 10.1002/ajmg.a.33743. [DOI] [PubMed] [Google Scholar]
- 56.Czeschik J C, Bauer P, Buiting K. et al. X-linked intellectual disability type Nascimento is a clinically distinct, probably underdiagnosed entity. Orphanet J Rare Dis. 2013;8:146. doi: 10.1186/1750-1172-8-146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Thunstrom S, Sodermark L, Ivarsson L, Samuelsson L, Stefanova M. UBE2A deficiency syndrome: a report of two unrelated cases with large Xq24 deletions encompassing UBE2A gene. Am J Med Genet A. 2015;167A(1):204–210. doi: 10.1002/ajmg.a.36800. [DOI] [PubMed] [Google Scholar]
- 58.Budny B, Badura-Stronka M, Materna-Kiryluk A. et al. Novel missense mutations in the ubiquitination-related gene UBE2A cause a recognizable X-linked mental retardation syndrome. Clin Genet. 2010;77(6):541–551. doi: 10.1111/j.1399-0004.2010.01429.x. [DOI] [PubMed] [Google Scholar]
- 59.Honda S, Orii K O, Kobayashi J. et al. Novel deletion at Xq24 including the UBE2A gene in a patient with X-linked mental retardation. J Hum Genet. 2010;55(4):244–247. doi: 10.1038/jhg.2010.14. [DOI] [PubMed] [Google Scholar]
- 60.Abreu-González M, García-Delgado C, Cervantes A. et al. Clinical, cytogenetic, and biochemical analyses of a family with a t(3;13)(q26.2;p11.2): further delineation of 3q duplication syndrome. Case Rep Genet. 2013;2013:895259. doi: 10.1155/2013/895259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Wuyts W, Roland D, Lüdecke H J. et al. Multiple exostoses, mental retardation, hypertrichosis, and brain abnormalities in a boy with a de novo 8q24 submicroscopic interstitial deletion. Am J Med Genet. 2002;113(4):326–332. doi: 10.1002/ajmg.10845. [DOI] [PubMed] [Google Scholar]
